DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,393,568 | +2.8% | 2,558,563 | 0.0% | 0.13% | +1.6% |
| Q2 2023 | $30,549,242 | +46.6% | 2,558,563 | +64.2% | 0.12% | +27.6% |
| Q1 2023 | $20,837,987 | -37.9% | 1,558,563 | 0.0% | 0.10% | -41.7% |
| Q4 2022 | $33,540,276 | +7.4% | 1,558,563 | 0.0% | 0.17% | +16.7% |
| Q3 2022 | $31,218,000 | -6.1% | 1,558,563 | -16.1% | 0.14% | -5.3% |
| Q2 2022 | $33,248,000 | +189.6% | 1,857,424 | +60.5% | 0.15% | +230.4% |
| Q1 2022 | $11,482,000 | -41.1% | 1,157,424 | 0.0% | 0.05% | -17.9% |
| Q4 2021 | $19,503,000 | -32.2% | 1,157,424 | -4.5% | 0.06% | -29.1% |
| Q3 2021 | $28,746,000 | -5.9% | 1,211,396 | -9.7% | 0.08% | -15.1% |
| Q2 2021 | $30,544,000 | – | 1,341,396 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |